FDLI Enforcement, Litigation and Compliance Conference 2021

Washington, D.C. litigation head Jennifer Bragg and Boston life sciences and health care partner Maya Florence participated in the Food and Drug Law Institute’s annual Enforcement, Litigation and Compliance Conference, held December 9-10. Ms. Bragg moderated a session titled “Compliance Central With FDA Center Compliance Directors: Presentations and Q&A,” which addressed some of the Food and Drug Administration’s top compliance issues, enforcement priorities and goals. Ms. Florence moderated a session titled “Enforcement and Compliance Issues and Their Impact on Due Diligence in Transactions Involving FDA-Regulated Companies and Products,” which discussed the key regulatory, clinical or quality issues that must be reviewed when purchasing an FDA-regulated product or company, and how to address those concerns in the due diligence phase.